(Q50779352)

19 March 2018

title

Predictive value of dopamine transporter SPECT imaging with [¹²³I]PE2I in patients with subtle parkinsonian symptoms (English)

1 reference

19 March 2018

1 reference

6

1 reference

19 March 2018

Gitte Moos Knudsen

7

1 reference

19 March 2018

Morten Ziebell

1

object named as

Morten Ziebell

0 references

Lars Hageman Pinborg

4

object named as

Lars H Pinborg

0 references

author name string

Birgitte B Andersen

2

1 reference

19 March 2018

Gerda Thomsen

3

1 reference

19 March 2018

Merete Karlsborg

5

1 reference

19 March 2018

publication date

18 November 2011

1 reference

19 March 2018

European Journal of Nuclear Medicine and Molecular Imaging

number of pages

9

0 references

published in

1 reference

19 March 2018

volume

39

1 reference

19 March 2018

issue

2

1 reference

19 March 2018

page(s)

242-250

1 reference

19 March 2018

Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: Part 1. Baseline and 3‐month observations

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Imaging of the dopaminergic system in differential diagnosis of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective co

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

MRI-guided region-of-interest delineation is comparable to manual delineation in dopamine transporter SPECT quantification in patients: a reproducibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Reproducibility of [123I]PE2I binding to dopamine transporters with SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Second consensus statement on the diagnosis of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Diagnostic criteria for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Diagnostic criteria for corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

How useful is [123I]beta-CIT SPECT in clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Early-stage [123I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

A double-blind, delayed-start trial of rasagiline in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1976-9

Criteria for the diagnosis of essential tremor

21 January 2018

1 reference

12 December 2020

Quantification of 123I-PE2I binding to dopamine transporter with SPECT after bolus and bolus/infusion.

1 reference

12 December 2020

Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes

1 reference

12 December 2020

Depression in Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects

1 reference

12 December 2020

Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease.

1 reference

12 December 2020

10.1007/S00259-011-1976-9

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018